Evrysdi Seen to Improve Survival, Motor Development of Infants with SMA Type 1

Mar 10, 2021, 12:00 AM

Headliner
Share
Subscribe
SMA News Today’s multimedia associate, Price Wooldridge, discusses Evrysdi improving survival and motor development in infants with Spinal Muscular Atrophy Type 1.
Forums Director Kevin Schaefer talks about managing his mental health and embracing the stillness.
Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/
Share
Subscribe
Next
CHMP Favors EU Approval of Evrysdi as 1st Oral, At-home SMA Treatment & Discussing GI Issues
Top episodes
Baby Girl's Family Brought From The UK to Ohio For Zolgensma Treatment & Maid of Honor
by The Spinal Muscular Atrophy Podcast with Kevin Schaefer
Saudi Arabian Doctors Need To Be More Aware of Guidelines & Benefits of Eye Tracking Tech
by The Spinal Muscular Atrophy Podcast with Kevin Schaefer
Mom of a Child Who Lived Through Death With SMA and Through Life With Spinraza
by The Spinal Muscular Atrophy Podcast with Kevin Schaefer